152 related articles for article (PubMed ID: 23820954)
21. Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.
Thomas S; Chigurupati S; Anbalagan M; Shah G
Mol Endocrinol; 2006 Aug; 20(8):1894-911. PubMed ID: 16574742
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores.
Ikenberg K; Fritzsche FR; Zuerrer-Haerdi U; Hofmann I; Hermanns T; Seifert H; Müntener M; Provenzano M; Sulser T; Behnke S; Gerhardt J; Mortezavi A; Wild P; Hofstädter F; Burger M; Moch H; Kristiansen G
BMC Cancer; 2010 Jun; 10():341. PubMed ID: 20591150
[TBL] [Abstract][Full Text] [Related]
23. Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases.
Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
Mod Pathol; 2006 Jul; 19(7):931-41. PubMed ID: 16575399
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients.
Shah GV; Rayford W; Noble MJ; Austenfeld M; Weigel J; Vamos S; Mebust WK
Endocrinology; 1994 Feb; 134(2):596-602. PubMed ID: 8299557
[TBL] [Abstract][Full Text] [Related]
25. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
[TBL] [Abstract][Full Text] [Related]
26. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
27. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
28. Calcitonin and calcitonin gene-related peptide in the human prostate gland.
Abrahamsson PA; Dizeyi N; Alm P; di Sant'Agnese PA; Deftos LJ; Aumüller G
Prostate; 2000 Aug; 44(3):181-6. PubMed ID: 10906733
[TBL] [Abstract][Full Text] [Related]
29. Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: evidence for iCT secretion by cultured prostate cells.
Shah GV; Noble MJ; Austenfeld M; Weigel J; Deftos LJ; Mebust WK
Prostate; 1992; 21(2):87-97. PubMed ID: 1409122
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
31. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.
Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
Histopathology; 2007 Apr; 50(5):648-58. PubMed ID: 17394502
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
33. Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression.
Li Q; Shi Y; Sa R; Hao J; Hu J; Xiao M; Wang C; Yan L; Qiao B; Chen G
BMC Cancer; 2020 Jun; 20(1):555. PubMed ID: 32539763
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
35. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer.
Liao Y; Grobholz R; Abel U; Trojan L; Michel MS; Angel P; Mayer D
Int J Cancer; 2003 Nov; 107(4):676-80. PubMed ID: 14520710
[TBL] [Abstract][Full Text] [Related]
36. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.
Huang D; Casale GP; Tian J; Wehbi NK; Abrahams NA; Kaleem Z; Smith LM; Johansson SL; Elkahwaji JE; Hemstreet GP
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1371-81. PubMed ID: 17623804
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia.
de la Torre M; Eklöv S; Häggman M; Björk P; Busch C; Nilsson S
Prostate; 1994 Sep; 25(3):125-31. PubMed ID: 7520576
[TBL] [Abstract][Full Text] [Related]
38. Expression of tissue factor in prostate cancer correlates with malignant phenotype.
Kaushal V; Mukunyadzi P; Siegel ER; Dennis RA; Johnson DE; Kohli M
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):1-6. PubMed ID: 18091328
[TBL] [Abstract][Full Text] [Related]
39. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
[TBL] [Abstract][Full Text] [Related]
40. WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.
Lin B; Utleg AG; Gravdal K; White JT; Halvorsen OJ; Lu W; True LD; Vessella R; Lange PH; Nelson PS; Hood L; Kalland KH; Akslen LA
Clin Cancer Res; 2008 Mar; 14(5):1397-406. PubMed ID: 18316561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
